Used in biomedical research to quantify levels of Protein Kinase C beta I in cell lysates, tissue extracts, and biological fluids. Enables researchers to study PKC βI involvement in signal transduction pathways, cell proliferation, differentiation, and apoptosis. Commonly applied in studies related to diabetes, cardiovascular diseases, and cancer where PKC βI activity is dysregulated. Supports high-throughput screening of potential therapeutic compounds that modulate PKC βI expression or activation. Provides a reliable, sensitive, and specific method for monitoring changes in PKC βI during experimental treatments.